104 related articles for article (PubMed ID: 1854611)
1. The prognostic value of immunoperoxidase staining with monoclonal antibodies NCRC-11 and 3E1.2 in breast cancer.
Muir IM; Reed RG; Stacker SA; Alexander AI; McKenzie IF; Bennett RC
Br J Cancer; 1991 Jul; 64(1):124-7. PubMed ID: 1854611
[TBL] [Abstract][Full Text] [Related]
2. Survival in breast cancer related to tumour oestrogen receptor status and immunohistochemical staining for NCRC 11.
Angus B; Napier J; Purvis J; Ellis IO; Hawkins RA; Carpenter F; Horne CH
J Pathol; 1986 Aug; 149(4):301-6. PubMed ID: 3020217
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator.
Ellis IO; Hinton CP; MacNay J; Elston CW; Robins A; Owainati AA; Blamey RW; Baldwin RW; Ferry B
Br Med J (Clin Res Ed); 1985 Mar; 290(6472):881-3. PubMed ID: 3919829
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in breast cancer: immunohistochemical staining for SP1 and NCRC 11 related to survival, tumour epidermal growth factor receptor and oestrogen receptor status.
Wright C; Angus B; Napier J; Wetherall M; Udagawa Y; Sainsbury JR; Johnston S; Carpenter F; Horne CH
J Pathol; 1987 Dec; 153(4):325-31. PubMed ID: 2828590
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas.
Wilkinson MJ; Howell A; Harris M; Taylor-Papadimitriou J; Swindell R; Sellwood RA
Int J Cancer; 1984 Mar; 33(3):299-304. PubMed ID: 6365800
[TBL] [Abstract][Full Text] [Related]
6. Immunoperoxidase staining in the detection of lymph node metastases in stage I breast cancer.
Raymond WA; Leong AS
Pathology; 1989 Jan; 21(1):11-5. PubMed ID: 2474791
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma.
Ellis IO; Bell J; Todd JM; Williams M; Dowle C; Robins AR; Elston CW; Blamey RW; Baldwin RW
Br J Cancer; 1987 Sep; 56(3):295-9. PubMed ID: 3663477
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical detection of epidermal growth factor receptor (EGF-R) in paraffin sections of breast carcinoma tissue: correlation and clinical significance].
Beckmann MW; Tutschek B; Göhring UJ; Engels K; Picard FK; Scharl A; Niederacher D; Schnürch HG
Geburtshilfe Frauenheilkd; 1995 May; 55(5):258-65. PubMed ID: 7607382
[TBL] [Abstract][Full Text] [Related]
9. Is apocrine differentiation in breast carcinoma of prognostic significance?
Bundred NJ; Walker RA; Everington D; White GK; Stewart HJ; Miller WR
Br J Cancer; 1990 Jul; 62(1):113-7. PubMed ID: 2202419
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer.
Platt-Higgins AM; Renshaw CA; West CR; Winstanley JH; De Silva Rudland S; Barraclough R; Rudland PS
Int J Cancer; 2000 Mar; 89(2):198-208. PubMed ID: 10754500
[TBL] [Abstract][Full Text] [Related]
11. NCRC-11 immunoperoxidase staining patterns in breast cancer: interpretive and technical reproducibility.
Muir IM; Ellis IO; Bell J; Robins RA
Histopathology; 1987 Nov; 11(11):1208-10. PubMed ID: 3319872
[No Abstract] [Full Text] [Related]
12. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.
Harbeck N; Untch M; Pache L; Eiermann W
Br J Cancer; 1994 Mar; 69(3):566-71. PubMed ID: 7510120
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi OP
J Clin Oncol; 1993 Jan; 11(1):36-43. PubMed ID: 8093367
[TBL] [Abstract][Full Text] [Related]
14. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancer.
Berry N; Jones DB; Smallwood J; Taylor I; Kirkham N; Taylor-Papadimitriou J
Br J Cancer; 1985 Feb; 51(2):179-86. PubMed ID: 2578285
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of cytosolic p53 protein in breast cancer.
Montero S; Guzmán C; Vargas C; Ballestín C; Cortés-Funes H; Colomer R
Tumour Biol; 2001; 22(5):337-44. PubMed ID: 11553865
[TBL] [Abstract][Full Text] [Related]
17. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
18. [C-erbB-2, EGF receptor, p53 and PCNA. The prognostic significance of recent tumor markers for lymph node negative breast cancer].
Schönborn I; Minguillon C; Lichtenegger W; Zschiesche W; Spitzer E
Geburtshilfe Frauenheilkd; 1995 Oct; 55(10):566-71. PubMed ID: 8543129
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
Cheang MC; Treaba DO; Speers CH; Olivotto IA; Bajdik CD; Chia SK; Goldstein LC; Gelmon KA; Huntsman D; Gilks CB; Nielsen TO; Gown AM
J Clin Oncol; 2006 Dec; 24(36):5637-44. PubMed ID: 17116944
[TBL] [Abstract][Full Text] [Related]
20. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
